Works matching IS 00099236 AND DT 2022 AND VI 112 AND IP 3
Results: 32
More Than Pharmacokinetics: Transporters in Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 423, doi. 10.1002/cpt.2710
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 421, doi. 10.1002/cpt.2708
- Publication type:
- Article
ASCPT News.
- Published in:
- 2022
- Publication type:
- Proceeding
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 427, doi. 10.1002/cpt.2702
- Publication type:
- Article
Trends in FDA Transporter‐Based Post‐Marketing Requirements and Commitments Over the Last Decade.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 635, doi. 10.1002/cpt.2701
- By:
- Publication type:
- Article
Exposure of Fexofenadine, but Not Pseudoephedrine, Is Markedly Decreased by Green Tea Extract in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 627, doi. 10.1002/cpt.2682
- By:
- Publication type:
- Article
Clinical Relevance of Organic Anion Transporting Polypeptide 1B–Mediated Hepatic Uptake for High‐Permeability Drugs: A Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 446, doi. 10.1002/cpt.2678
- Publication type:
- Article
Genomewide Association Study of Simvastatin Pharmacokinetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 676, doi. 10.1002/cpt.2674
- By:
- Publication type:
- Article
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 615, doi. 10.1002/cpt.2672
- By:
- Publication type:
- Article
Current Perspective on Residual Knowledge Gaps in the Assessment of Transporter‐Mediated Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 450, doi. 10.1002/cpt.2671
- By:
- Publication type:
- Article
Clinical Relevance of Hepatic and Renal P‐gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 573, doi. 10.1002/cpt.2670
- By:
- Publication type:
- Article
Challenges and Opportunities for Improved Drug–Drug Interaction Predictions for Renal OCT2 and MATE1/2‐K Transporters.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 562, doi. 10.1002/cpt.2666
- By:
- Publication type:
- Article
Protecting the Kidney: The Unexpected Logic of Inhibiting a Glucose Transporter.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 434, doi. 10.1002/cpt.2651
- By:
- Publication type:
- Article
Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug–Drug Interaction Studies?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 453, doi. 10.1002/cpt.2650
- By:
- Publication type:
- Article
Tiny Gatekeepers: Microbial Control of Host Drug Transporters.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 443, doi. 10.1002/cpt.2647
- By:
- Publication type:
- Article
Reduced All‐Cause Mortality With Bisphosphonates Among Post‐Fracture Osteoporosis Patients: A Nationwide Study and Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 711, doi. 10.1002/cpt.2645
- By:
- Publication type:
- Article
Transporters in Drug Development: International Transporter Consortium Update on Emerging Transporters of Clinical Importance.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 485, doi. 10.1002/cpt.2644
- By:
- Publication type:
- Article
Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 501, doi. 10.1002/cpt.2643
- By:
- Publication type:
- Article
Effect of Chronic Kidney Disease on the Renal Secretion via Organic Anion Transporters 1/3: Implications for Physiologically‐Based Pharmacokinetic Modeling and Dose Adjustment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 643, doi. 10.1002/cpt.2642
- By:
- Publication type:
- Article
Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment‐Refractory Depression.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 720, doi. 10.1002/cpt.2640
- By:
- Publication type:
- Article
Accelerating SLC Transporter Research: Streamlining Knowledge and Validated Tools.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 439, doi. 10.1002/cpt.2639
- By:
- Publication type:
- Article
Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 527, doi. 10.1002/cpt.2638
- By:
- Publication type:
- Article
Renal Transporter‐Mediated Drug‐Biomarker Interactions of the Endogenous Substrates Creatinine and N<sup>1</sup>‐Methylnicotinamide: A PBPK Modeling Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 687, doi. 10.1002/cpt.2636
- By:
- Publication type:
- Article
A Biological Basis for Pharmacokinetics: The Remote Sensing and Signaling Theory.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 456, doi. 10.1002/cpt.2634
- By:
- Publication type:
- Article
Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 699, doi. 10.1002/cpt.2633
- By:
- Publication type:
- Article
Blockade of Organic Anion Transport in Humans After Treatment With the Drug Probenecid Leads to Major Metabolic Alterations in Plasma and Urine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 653, doi. 10.1002/cpt.2630
- By:
- Publication type:
- Article
New and Emerging Research on Solute Carrier and ATP Binding Cassette Transporters in Drug Discovery and Development: Outlook From the International Transporter Consortium.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 540, doi. 10.1002/cpt.2627
- By:
- Publication type:
- Article
Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 461, doi. 10.1002/cpt.2605
- By:
- Publication type:
- Article
Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 665, doi. 10.1002/cpt.2594
- By:
- Publication type:
- Article
Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 605, doi. 10.1002/cpt.2593
- By:
- Publication type:
- Article
Prediction of Hepatobiliary Clearances and Hepatic Concentrations of Transported Drugs in Humans Using Rosuvastatin as a Model Drug.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 593, doi. 10.1002/cpt.2556
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 413, doi. 10.1002/cpt.2300
- Publication type:
- Article